Proton Partners site deploys beam precision technology

Oncology Systems Limited medical physicist Asia Baginska, Proton Partners International senior medical physicist Josephine Clorley, deputy head of physics Ignacio Di Biase and head of physics John Pettingell.

The first ever Proton Partners International site, specialising in proton beam therapy, has acquired a Blue Phantom2 data acquisition system from IBA to commission its IBA ProteusONE compact proton therapy machine and Elekta Versa HD linear accelerator.  Distributed by Oncology Systems Limited, Blue Phantom2 is used to implement beam shaping precision for patient treatment plans.

Proton Partners International head of physics John Pettingell said: “We’re using the Blue Phantom2 water tank to measure the beam data required to model our linac beams in the treatment planning system.  There’s a lot of experience behind the hardware and software; it is well developed, flexible and very easy to use which makes the commissioning process quicker and more straightforward.  We use our beam models to plan patient treatments, so the more accurate data we can take, the more accurate our treatments will be.  The Blue Phantom2 uses a magnetic detector positioning system accurate to 0.1mm, so we have great confidence in the quality of our data.”

See the full report on page 32 of the February 2017 issue of RAD Magazine.